For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It’s completely free and we guarantee you’ll learn something new every day.
While the world’s leading biotech companies churning out Covid-19 vaccines and treatments have hit record share prices, their small-cap rivals have been sinking. But some analysts say the latest figures suggest a bargain in the sector.
Alone In The Red
Pfizer’s share price hit a record high for the first time in 20 years this month, topping $48, while vaccine partner....More>>>